To include your compound in the COVID-19 Resource Center, submit it here.

Eyetech completes AMD Phase III enrollment

Eyetech (New York, N.Y.) completed enrollment of 1,196 patients

Read the full 92 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE